BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report fi…
ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons winter meeting, Michael Amon, MD, talks about the advantages of add-on lenses, a removable and adjustable technology that he believes adapts well to the changes of the aging eye.
Scientists have identified a key mechanism that damages the cornea in Meesmann epithelial corneal dystrophy, a rare blinding disorder, which is passed from parents to their children.
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/nhqn5v/global_contact) has announced the addition of the “Global Contact Lenses & Intraocular Lenses Market Assessment & Forecast: 2015-2019” report to their offering. The North American market is anticipated to continue leading in terms of value due to ease of availability, higher awareness and diagnosis, greater number of ophthalmologists and optometrists per 1000 people as compared to other regi
ATHENS, Greece — Cosmetic iris implants are a non-approved, high-risk procedure that can lead to severe, potentially blinding complications in the majority of cases, a speaker said at the European Society of Cataract and Refractive Surgeons winter meeting. Wajiha Kheir, MD, told the audience that 700 procedures were performed with the NewIris implant (Kahn Medical Devices) since 2010 and that many complications have been reported, including increased IOP, iritis with keratic precipitates, corneal edema and hyphema. Use of the implant was discontinued because of irreversible ocular damage.
The chair of ophthalmology at the University of Michigan examined a recent report investigating the value of vision screening for older adults with no symptoms.